Dr Reddy’s Laboratories said that its wholly owned subsidiary, Dr. Reddy’s USA and Ingenus Pharmaceuticals has entered into license agreement to commercialise Cyclophosphamide Injection RTD in United States (US).
Subscribe To Our Free Newsletter |
Dr Reddy’s Laboratories said that its wholly owned subsidiary, Dr. Reddy’s USA and Ingenus Pharmaceuticals has entered into license agreement to commercialise Cyclophosphamide Injection RTD in United States (US).
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!